| Genomic analysis of diffuse intrinsic pontine gliomas identifies three molecular subgroups and recurrent activating ACVR1 mutations P Buczkowicz, C Hoeman, P Rakopoulos, S Pajovic, L Letourneau, ... Nature genetics 46 (5), 451-456, 2014 | 622 | 2014 |
| Dietary restriction reduces insulin-like growth factor I levels, which modulates apoptosis, cell proliferation, and tumor progression in p53-deficient mice SE Dunn, FW Kari, J French, JR Leininger, G Travlos, R Wilson, JC Barrett Cancer research 57 (21), 4667-4672, 1997 | 543 | 1997 |
| Phosphorylated insulin-like growth factor-i/insulin receptor is present in all breast cancer subtypes and is related to poor survival JH Law, G Habibi, K Hu, H Masoudi, MYC Wang, AL Stratford, E Park, ... Cancer research 68 (24), 10238-10246, 2008 | 467 | 2008 |
| Recurrence patterns across medulloblastoma subgroups: an integrated clinical and molecular analysis V Ramaswamy, M Remke, E Bouffet, CC Faria, S Perreault, YJ Cho, ... The lancet oncology 14 (12), 1200-1207, 2013 | 395 | 2013 |
| A dominant negative mutant of the insulin-like growth factor-I receptor inhibits the adhesion, invasion, and metastasis of breast cancer SE Dunn, M Ehrlich, NJH Sharp, K Reiss, G Solomon, R Hawkins, ... Cancer research 58 (15), 3353-3361, 1998 | 376 | 1998 |
| Akt phosphorylates the Y-box binding protein 1 at Ser102 located in the cold shock domain and affects the anchorage-independent growth of breast cancer cells BW Sutherland, J Kucab, J Wu, C Lee, MCU Cheang, E Yorida, D Turbin, ... Oncogene 24 (26), 4281-4292, 2005 | 364 | 2005 |
| Divergent clonal selection dominates medulloblastoma at recurrence AS Morrissy, L Garzia, DJH Shih, S Zuyderduyn, X Huang, P Skowron, ... Nature 529 (7586), 351-357, 2016 | 342 | 2016 |
| FOXA1 expression in breast cancer--correlation with luminal subtype A and survival. NH Badve S1, Turbin D, Thorat MA, Morimiya A, Nielsen TO, Perou CM, Dunn S ... Clin Cancer Res. 13 (15 Pt 1), 4415-21, 2007 | 318 | 2007 |
| Insulin-like growth factor 1 (IGF-1) alters drug sensitivity of HBL100 human breast cancer cells by inhibition of apoptosis induced by diverse anticancer drugs SE Dunn, RA Hardman, FW Kari, JC Barrett Cancer research 57 (13), 2687-2693, 1997 | 297 | 1997 |
| Molecular profiling identifies prognostic subgroups of pediatric glioblastoma and shows increased YB-1 expression in tumors D Faury, A Nantel, SE Dunn, MC Guiot, T Haque, P Hauser, M Garami, ... Journal of Clinical Oncology 25 (10), 1196-1208, 2007 | 272 | 2007 |
| Hierarchical clustering analysis of tissue microarray immunostaining data identifies prognostically significant groups of breast carcinoma NA Makretsov, DG Huntsman, TO Nielsen, E Yorida, M Peacock, ... Clinical cancer research 10 (18), 6143-6151, 2004 | 243 | 2004 |
| YB-1: oncoprotein, prognostic marker and therapeutic target? BAW Lasham A1, Print CG, Woolley AG, Dunn SE Biochem J. 449 (1), 11-23, 2013 | 231 | 2013 |
| Disruption of the Y-box binding protein-1 results in suppression of the epidermal growth factor receptor and HER-2 J Wu, C Lee, D Yokom, H Jiang, MCU Cheang, E Yorida, D Turbin, ... Cancer research 66 (9), 4872-4879, 2006 | 209 | 2006 |
| Y-Box Binding Protein-1 Induces the Expression of CD44 and CD49f Leading to Enhanced Self-Renewal, Mammosphere Growth, and Drug Resistance K To, A Fotovati, KM Reipas, JH Law, K Hu, J Wang, A Astanehe, ... Cancer research 70 (7), 2840-2851, 2010 | 206 | 2010 |
| Epidermal growth factor receptor (EGFR) is transcriptionally induced by the Y-box binding protein-1 (YB-1) and can be inhibited with Iressa in basal-like breast cancer … AL Stratford, G Habibi, A Astanehe, H Jiang, K Hu, E Park, A Shadeo, ... Breast cancer research 9, 1-14, 2007 | 183 | 2007 |
| Identification of ROCK1 kinase as a critical regulator of Beclin1-mediated autophagy during metabolic stress AU Gurkar, K Chu, L Raj, R Bouley, SH Lee, YB Kim, SE Dunn, ... Nature communications 4 (1), 1-13, 2013 | 176 | 2013 |
| Y-box binding protein-1 serine 102 is a downstream target of p90 ribosomal S6 kinase in basal-like breast cancer cells AL Stratford, CJ Fry, C Desilets, AH Davies, YY Cho, Y Li, Z Dong, ... Breast Cancer Research 10, 1-12, 2008 | 170 | 2008 |
| Preferential dependence of breast cancer cells versus normal cells on integrin-linked kinase for protein kinase B/Akt activation and cell survival AA Troussard, PC McDonald, ED Wederell, NM Mawji, NR Filipenko, ... Cancer research 66 (1), 393-403, 2006 | 166 | 2006 |
| Redefining prognostic factors for breast cancer: YB-1 is a stronger predictor of relapse and disease-specific survival than estrogen receptor or HER-2 across all tumor subtypes G Habibi, S Leung, JH Law, K Gelmon, H Masoudi, D Turbin, M Pollak, ... Breast Cancer Research 10, 1-9, 2008 | 157 | 2008 |
| Disulfiram, a drug widely used to control alcoholism, suppresses self-renewal of glioblastoma and overrides resistance to temozolomide J Triscott, C Lee, K Hu, A Fotovati, R Berns, M Pambid, M Luk, RE Kast, ... Oncotarget 3 (10), 1112, 2012 | 149 | 2012 |
